Cardiovascular and noncardiovascular mortality among patients starting dialysis

JAMA

Volumn 302, Issue 16, 2009, Pages 1782-1789

  De Jager, Dinanda J ^a   Grootendorst, Diana C ^a   Jager, Kitty J ^b   Van Dijk, Paul C ^b   Tomas, Lonneke M J ^a   Ansell, David ^c   Collart, Frederic ^d   Finne, Patrik ^e   Heaf, James G ^f   De Meester, Johan ^g   Wetzels, Jack F M ^h   Rosendaal, Frits R ^a   Dekker, Friedo W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UK RENAL REGISTRY   (United Kingdom)

^d French Speaking Belgium Renal Registry   (Belgium)

^e Finnish Registry for Kidney Diseases   (Finland)

^f Mental Health Services CPH   (Denmark)

^g AZ Nikolaas   (Belgium)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CACHEXIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; EUROPE; FEMALE; FOLLOW UP; HEART ARREST; HEART INFARCTION; HUMAN; INFECTION; INTERNATIONAL CLASSIFICATION OF DISEASES; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDE; TREATMENT REFUSAL; CHRONIC KIDNEY FAILURE; MIDDLE AGED; REGISTER; RENAL REPLACEMENT THERAPY; RISK;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; REGISTRIES; RENAL DIALYSIS; RISK; YOUNG ADULT;

EID: 70350741160     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1488     Document Type: Article

References (40)

1. Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol. 2007;18(7):2125-2134. (Pubitemid 47041078)
2. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol. 1994;5(5):1231-1242.
3. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290(13):697-701.
4. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5)(suppl 3):S112-S119. (Pubitemid 28527268)
5. Cheung AK, Sarnak MJ, Yan G, et al; HEMO Study Group. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int. 2004;65(6):2380-2389. (Pubitemid 38670024)
6. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(12)(suppl):S16-S23.
7. Stel VS, van Dijk PC, van Manen JG, et al. Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation. Nephrol Dial Transplant. 2005;20(12):2803-2811.
8. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186-192.
9. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis. 1992;20(5)(suppl 2):32-38.
10. Garg AX, Clark WF, Haynes RB, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int. 2002;61(4):1486-1494. (Pubitemid 34304510)
11. Lastra G, Manrique C, Sowers JR. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis. 2006;13(4):365-373. (Pubitemid 44512240)
12. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58(1):353-362. (Pubitemid 30429882)
13. Locatelli F, Bommer J, London GM, et al. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol Dial Transplant. 2001;16(3):459-468. (Pubitemid 32229274)
14. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339(12):799-805. (Pubitemid 28447453)
15. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305. (Pubitemid 39268908)
16. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15(5):1307-1315. (Pubitemid 38526012)
17. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285-1295.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4)(suppl 3):S1-S153.
19. Stenvinkel P, Karimi M, Johansson S, et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med. 2007;261(5):488-499. (Pubitemid 46587721)
20. Jager KJ, van Dijk PC, Dekker FW, Cornet R, Krediet RT, Briggs JD. The European Registry: where do we stand? Perit Dial Int. 2000;20(suppl 2):S118-S120. (Pubitemid 30410569)
21. van Dijk PC, Jager KJ, de Charro F, et al; ERAEDTA Registry. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA Registry and six national or regional registries. Nephrol Dial Transplant. 2001;16(6):1120-1129.
22. European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry. ERAEDTA Registry 2006 Annual Report. Amsterdam, the Netherlands: ERA-EDTA; 2007:129.
23. Causes of death - absolute number. European Commission Web site. http://nui.epp.eurostat.ec.europa.eu/nui/show.do?dataset=hlth-cd-anr&lang= en. Accessed July 28, 2009.
24. Population at 1st January by sex and age from 1990 onwards. European Commission Web site. http://nui.epp.eurostat.ec.europa.eu/nui/show.do?dataset= reg-d2jan&lang=en. Accessed July 28, 2009.
25. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
26. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. US Renal Data System Web site. http://www.usrds.org/atlas.htm. 2008. Accessed July 28, 2009.
27. Foley RN. Infections and cardiovascular disease in patients with chronic kidney disease. Adv Chronic Kidney Dis. 2006;13(3):205-208. (Pubitemid 43947732)
28. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354(9173):93-99. (Pubitemid 29313142)
29. Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol. 2001;12(7):1516-1523. (Pubitemid 32666335)
30. Shanahan CM. Vascular calcification. Curr Opin Nephrol Hypertens. 2005;14(4):361-367.
31. Ketteler M, Giachelli C. Novel insights into vascular calcification. Kidney Int Suppl. 2006;(105):S5-S9.
32. Stompór T. An overview of the pathophysiology of vascular calcification in chronic kidney disease. Perit Dial Int. 2007;27(suppl 2):S215-S222. (Pubitemid 350047704)
33. Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526-1533.
34. Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis. 2005;46(2):186-202. (Pubitemid 41040347)
35. Aucella F, Maas R, Vigilante M, et al. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study [published online ahead of print May 21, 2009]. Atherosclerosis. doi: 10.1016/j. atherosclerosis.2009.05.011.
36. Fried LP, Tangen CM, Walston J, et al; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156.
37. Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18(11):2960-2967.
38. Havekes B, van Manen JG, Krediet RT, Boeschoten EW, Vandenbroucke JP, Dekker FW; NECOSAD Study Group. Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2006;47(5):823-829.
39. Hermans MM, Brandenburg V, Ketteler M, et al; Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD). Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int. 2007;72(2):202-207.
40. den Elzen WP, van Manen JG, Boeschoten EW, Krediet RT, Dekker FW. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. Nephrol Dial Transplant. 2006;21(6):1588-1595.